Researchers at Great Ormond Street Hospital (GOSH) have taken the first steps towards using stem cells to repair damaged gut tissue in a pioneering new study that could hold promise for children and adults with serious gastrointestinal disorders.
AI bodysuit trial launched to help treat Duchenne muscular dystrophy
1 Feb 2018, 11:57 a.m.
A new artificially intelligent bodysuit to help understand how mobility is affected in boys with Duchenne will be trialled in a collaboration between researchers at Great Ormond Street Hospital (GOSH) and Imperial College London.
Catalyst Fellowships launched to support talented child health researchers
14 Dec 2017, 4:32 p.m.
The Catalyst Fellowships are an exciting new initiative supported by the National Institute for Health Research (NIHR) Great Ormond Street Hospital (GOSH) Biomedical Research Centre aiming to build the capacity of child health researchers and enabling the
New genetic test leads to faster, more accurate diagnosis of childhood eye disorders
11 Dec 2017, 11:21 a.m.
A new test to help diagnose and predict a range of serious childhood eye conditions has been developed by researchers at Great Ormond Street Hospital (GOSH) and the UCL Great Ormond Street Institute of Child Health (ICH).
Low myostatin levels linked to lack of success of anti-myostatin drugs for muscle-wasting conditions
30 Nov 2017, 2:04 p.m.
Levels of myostatin, a protein that prevents muscle growth, could influence how well the body responds to anti-myostatin treatments for muscle-wasting conditions such as Duchenne Muscular Dystrophy (DMD). This breakthrough could help predict which patient